RxDoctor Payments Data

John Gherman, MD

Psychiatry · Petoskey, MINPI 1780626788

Payments from drug & device makers

$202in general payments, 2019–2025

Across 12 payments — averaging $16.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$52
  • Alkermes, Inc.$32
  • AbbVie$32
  • Vanda Pharmaceuticals Inc.$20
  • Otsuka America Pharmaceutical, Inc.$20
  • Teva Pharmaceuticals USA, Inc.$17
  • plus $29 from 2 others

What the payments were for

  • Food & beverage$17184%
  • Education$3216%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$202 in reported general payments places this provider in the 50th percentile of 1,166 psychiatry providers in Michigan.

See all psychiatry providers in Michigan

Medicare billing

Part B allowed, 2024
$14,890
Medicare patients
52
Services billed
270

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate94$277,041
Invega TrinzaPaliperidone Palmitate21$202,545
AustedoDeutetrabenazine44$186,557
Abilify MaintenaAripiprazole28$77,744
VraylarCariprazine Hcl20$31,565
ZyprexaOlanzapine14$18,802
Quetiapine Fumarate ErQuetiapine Fumarate45$10,474
TrintellixVortioxetine Hydrobromide19$9,357
Clozapine87$8,379
Paliperidone ErPaliperidone52$6,108
Lamotrigine ErLamotrigine45$5,717
Asenapine Maleate14$4,305
Divalproex Sodium ErDivalproex Sodium83$2,355
Oxcarbazepine72$2,307
Olanzapine156$2,299

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza$52$479,586115 claims
Teva Pharmaceuticals USA, Inc.Austedo$17$186,55744 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$20$77,74428 claims
AbbVieVraylar$32$31,56520 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,166 psychiatry providers in Michigan.

Other psychiatry in Petoskey

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →